Mapping the human genome has created an unprecedented opportunity to discover important disease targets that we believe will lead to innovative medical treatements. With thousands of disease targets on the horizon, medical science is presented with a unique challenge: how to turn those targets into new treatments rapidly and efficiently. For many targets, the answer may be monoclonal antibodies. These efficient tools of biotechnology have the potential to make new drug development much faster and less expensive than has been possible in the past.

By taking advantage of the benefits of monoclonal antibodies and leveraging our comprehensive antibody development system, Medarex plans to develop a wide range of therapeutic products based on the many new disease targets of the genomics era.

Antibody Structure

Antibody Evolution

Antibodies as Therapeutics